Rapid weight loss with GLP-1/GIP agents may lead to lean mass reduction, which could be concerning in RA patients already at risk for sarcopenia
Medication Transparency Patients should understand exactly which medication is being considered, why it may be appropriate, how it will be obtained, and what to expect during treatment
these are harder to quantify in studies but matter tremendously
Studies have demonstrated that progesterone facilitates GLUT1 expression by binding to progesterone receptor (PGR) and targeting downstream insulin receptor substrate 2 (IRS2), leading to downstream activation of mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3 kinase (PI3K/AKT) pathways, which critically support the human endometrial decidualization process to facilitate pregnancy (1618)
Can my regular doctor prescribe compounded semaglutide instead of a telehealth service
Sybille Buchwald-Werner Risa Schulman, PhD Callie Bonine Taylor Foxman Another great podcast sharing Allie Egan's story and the innovations we are building in Metabolic Health